한미약품, 2030년 매출 2조9000억 목표…비만치료제·신약 중심 4개 부문 체제로 전환
(서울=NSP통신) jeong seop park Jour = SK Bioscience, a leading South Korean bio company, is expeted to announce the record high 2021 earnings. The company plans to hold a press confernce next thursday. In the on-line confernce call, SK CEO plans to disclose the ongoing management issues including clinical trials for corona vaccines.
NSP News Agency jeong seop park Journalist desk@nspna.com
Copyright ⓒ Korea's economic news agency NSP NEWS·NSP TV. All rights reserved-Redistribution Prohibited.